Cabaletta Bio, Inc. — Director's Dealing 2022

Oct 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2022-10-18

Reporting Person: Simon Mark (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-18	Common Stock	P	118000	$0.977	Acquired	136144	Direct
2022-10-18	Common Stock	P	7000	$0.9764	Acquired	7000	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9315 to $0.99, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9375 to $0.9899, inclusive.